Publications by authors named "Virginia Platt"

Claim this Profile
C
Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases.
Wei-Jian Pan, Kathleen Köck, William A Rees, Barbara A Sullivan, Christine M Evangelista, Virginia M Platt

Br J Clin Pharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondria.
Do Yup Lee, Zhiyin Xun, Virginia Platt, Helen Budworth, Christie A Canaria

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards understanding region-specificity of triplet repeat diseases: coupled immunohistology and mass spectrometry imaging.
Virginia Platt, Do Yup Lee, Christie A Canaria, Ken Frankel, Susan Bernstein

Methods Mol Biol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolving brain regions using nanostructure initiator mass spectrometry imaging of phospholipids.
Do Yup Lee, Virginia Platt, Ben Bowen, Katherine Louie, Christie A Canaria

Integr Biol (Camb)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.
Douglas S Watson, Virginia M Platt, Limin Cao, Vincent J Venditto, Francis C Szoka

Clin Vaccine Immunol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein.
Virginia Platt, Zhaohua Huang, Limin Cao, Matthew Tiffany, Kareen Riviere

Bioconjug Chem· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor therapy mediated by 5-fluorocytosine and a recombinant fusion protein containing TSG-6 hyaluronan binding domain and yeast cytosine deaminase.
Joshua I Park, Limin Cao, Virginia M Platt, Zhaohua Huang, Robert A Stull

Mol Pharm· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
Virginia M Platt, Francis C Szoka

Mol Pharm· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis